Gastroenterology Research and Practice / 2023 / Article / Tab 2 / Research Article
Clinical Distribution Characteristics and Identification for Significant Liver Inflammation of Patients in Chronic Hepatitis B with Indeterminate Phase Table 2 Baseline characteristics of patients with liver mild and significant inflammation in the indeterminate phase.
Variables G0–1 ( ) G2–4 ( ) valueAge (year) 40.0 (34.0–47.0) 42.0 (33.0–49.0) 0.223 Sex (male%) 122 (60.4) 162 (67.8) 0.107 WBC (×109 /L) 5.4 (4.5–6.5) 5.4 (4.5–6.6) 0.895 PLT (×109 /L) 181.0 (153.0–220.3) 166.0 (138.0–206.0) 0.001 PT (s) 11.4 (11.0–11.9) 11.8 (11.2–12.3) <0.001 INR 1.0 (1.0–1.1) 1.0 (1.0–1.1) 0.002 ALB (g/L) 45.4 (42.7–48.1) 44.2 (41.8–46.6) 0.003 GLB (g/L) 27.6 (25.5–30.9) 28.6 (25.6–32.0) 0.045 ALT (U/L) 27.0 (19.0–47.3) 40.0 (26.0–63.0) <0.001 AST (U/L) 26.0 (21.0–32.5) 34.0 (26.0–45.0) <0.001 GGT (U/L) 19.5 (14.0–30.0) 25.0 (18.0–43.0) <0.001 ALP (U/L) 75.5 (60.8–91.0) 81.0 (62.0–99.0) 0.052 TBIL (μ mol/L) 13.0 (10.0–17.2) 14.3 (11.0–18.9) 0.155 Log10 (HBV-DNA IU/ml) 4.2 (3.6–4.9) 4.5 (3.9–5.5) 0.002 Log10 (HBsAg IU/ml) 2.4 (2.4–3.3) 2.4 (2.4–3.3) 0.536 Anti-HBC (S/CO) 11.2 (9.5–12.3) 11.2 (9.8–12.5) 0.493 Fibrosis (%) 0 56 (27.7) 11 (4.6) <0.001 1 100 (49.5) 61 (25.5) 2 38 (18.8) 84 (35.1) 3 7 (3.5) 41 (17.2) 4 1 (0.5) 42 (17.6)